Shree Ganesh Remedies Ltd
SGRLShree Ganesh Remedies Ltd
SGRL
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 30.24 | 6.90 | 0.08% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.72 | 6.72 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Shree Ganesh Remedies Limited is engaged in manufacturing and dispatching of drug intermediates and chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions etc.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2024 | TTM | ||
|---|---|---|---|---|
| Total Revenue | 128.97 | 118.51 | ||
Raw Materials | 63.36 | 73.43 | ||
| Power & Fuel Cost | 6.39 | |||
| Employee Cost | 8.41 | |||
| Selling & Administrative Expenses | 9.42 | |||
| Operating & Other expenses | -3.49 | |||
EBITDA | 44.88 | 45.08 | ||
| Depreciation/Amortization | 6.11 | 7.29 | ||
| PBIT | 38.77 | 37.79 | ||
| Interest & Other Items | 0.61 | 0.95 | ||
| PBT | 38.16 | 36.84 | ||
| Taxes & Other Items | 10.05 | 9.00 | ||
| Net Income | 28.11 | 27.84 | ||
| EPS | 21.88 | 21.67 | ||
| DPS | 0.50 | 0.00 | ||
| Payout ratio | 0.02 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Shree Ganesh Remedies Ltd | 29.95 | 6.90 | 0.08% |
| Sun Pharmaceutical Industries Ltd | 46.63 | 6.65 | 0.73% |
| Cipla Ltd | 29.52 | 4.54 | 0.86% |
| Mankind Pharma Ltd | 61.94 | 12.37 | — |
Price Comparison
Compare SGRL with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 7, 2023
Dividend/Share
₹0.50
Ex DateEx Date
Sep 7, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Dividend/Share
₹0.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Dividend/Share
₹1.75
Ex DateEx Date
Sep 8, 2021
Cash Dividend
Ex DateEx DateSep 1, 2020
Dividend/Share
₹1.50
Ex DateEx Date
Sep 1, 2020
Cash Dividend
Ex DateEx DateAug 22, 2019
Dividend/Share
₹1.25
Ex DateEx Date
Aug 22, 2019
Net profit of Shree Ganesh Remedies declined 1.98% to Rs 6.42 crore in the quarter ended September 2024 as against Rs 6.55 crore during the previous quarter ended September 2023. Sales declined 3.26% to Rs 32.33 crore in the quarter ended September 2024 as against Rs 33.42 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.3333.42 -3 OPM %34.9827.59 - PBDT11.0710.01 11 PBT8.658.60 1 NP6.426.55 -2 Powered by Capital Market - Live
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 29 October 2024.Powered by Capital Market - Live
Shree Ganesh Remedies announced that the 29th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 28 September 2024.Powered by Capital Market - Live
Net profit of Shree Ganesh Remedies rose 2.42% to Rs 4.65 crore in the quarter ended June 2024 as against Rs 4.54 crore during the previous quarter ended June 2023. Sales declined 7.26% to Rs 24.78 crore in the quarter ended June 2024 as against Rs 26.72 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales24.7826.72 -7 OPM %32.8524.59 - PBDT8.367.29 15 PBT6.346.27 1 NP4.654.54 2 Powered by Capital Market - Live
Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live
Increased Total Promoter Holding
In last 6 months, promoter holding in the company has increased by 1.16%
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant